Focused Shock wave Therapy for Dupuytren's Disease: A Literature Review
DOI:
https://doi.org/10.25759/spmfr.526Keywords:
Dupuytren’s Disease, Extracorporeal shock wave therapyAbstract
Dupuytren’s Disease is a progressive fibroproliferative condition of the palmar fascia, leading to digital contractures and functional impairment. Focused shock wave therapy has emerged as a non-invasive approach for managing this condition. This review aims to summarize the current evidence on the use of focal shock wave therapy in Dupuytren’s Disease, particularly regarding treatment parameters, pain reduction, quality of life and functional impact, joint range of motion and adverse effects. Available studies suggest that focused shock wave therapy in Dupuytren’s Disease appears to be a promising and non-invasive alternative, particularly for pain management and hand functionality improvement, with minimal adverse effects. However, the lack of standardized treatment protocols limits robust conclusions. Future research should include long-term follow-up and standardization of treatment parameters to better define the role of focal shock wave therapy in the management of Dupuytren’s Disease.
Downloads
References
Gudmundsson K, Jonsson T, Arngrimsson R. Guillameu Dupuytren and finger contractures. Lancet. 2003;362:165-8.
Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol. 2010;6:715-26.
Wilburn J, McKenna SP, Perry-Hinsley D, Bayat A. The impact of Dupuytren disease on patient activity and quality of life. J Hand Surg Am. 2013;38(6):1209-14.
Alser O, Craig RS, Lane JCE, Prats-Uribe A, Robinson DE, Rees JL, et al. Serious complications and risk of reoperation after Dupuytren's disease surgery: a population-based cohort study of 121,488 patients in England. Sci Rep. 2020;10:16520.
Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FTD, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361(10):968-79.
Zhang D, Earp BE, Benavent KA, Blazar P. Collagenase Treatment of Dupuytren's Disease with Minimum 5-Year Follow-Up: Recurrence, Reintervention, and Satisfaction. Plast Reconstr Surg. 2020;146:1071-9.
Eberlein B, Biedermann T. To remember: Radiotherapy - a successful treatment for early Dupuytren's disease. J Eur Acad Dermatol Venereol. 2016;30:1694-9.
Knobloch K, Kuehn M, Vogt PM. Focused extracorporeal shockwave therapy in Dupuytren's disease: a hypothesis. Med Hypotheses. 2011;76(5):635-7.
Perlick L, Gassel F, Zander D, Schmitt O, Wallny T. Vergleich der Ergebnisse der mittelenergetischen ESWT und der operation Therapy in der Technik nach Mittelmeier bei der therapieresistenten Epicondylitis humeri radialis. Z Orthop Ihre Grenzgeb. 1999;137(4):316-321.
International Society for Medical Shockwave Therapy (ISMST). ESWT guidelines. 2023.
Aykut S, Aydin C, Ozturk K, Arslanoğlu F, Kling C. Extracorporeal Shock Wave Therapy in Dupuytren's Disease. Silsli Eftal Hastan Tip Bul. 2018;52(2):124-128.
Knobloch K, Hellweg M, Sorg H, Nedelka T. Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease-a randomized controlled trial (Dupuyshock). Lasers Med Sci. 2022;37(1):323-333.
Abdulsalam AJ, Shehab D, Elhady AA, Abraham M. High-energy focused extracorporeal shockwave therapy relieved pain in Dupuytren's disease: a series of seven hands. Eur J Phys Rehabil Med. 2019;55(6):862-864.
Notarnicola A, Maccagnano G, Rifino F, Pesce V, Gallone MF, Covelli I, et al. Short-term effect of shockwave therapy, temperature controlled high energy adjustable multi-mode emission laser or stretching in Dupuytren's disease: a prospective randomized clinical trial. J Biol Regul Homeost Agents. 2017;31(3):775-784.
Taheri P, Salek N, Mousavi M, Maghroori R. The Effect of Shock Wave Therapy on Improving the Symptoms and Function of Patients with Dupuytren's Contracture. Adv Biomed Res. 2022;11:3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista da Sociedade Portuguesa de Medicina Física e de Reabilitação
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright statement
Authors must also submit a copyright statement (as seen below) on article submission.
To the Editor-in-chief of the SPMFR Journal:
The below signed author(s) hereby state that the article
________________________________________ (ref. MFR_________) is
an original unpublished work and all facts stated are a product of the author(s) investigation. This article does not violate any copyright laws or privacy statements. The author(s) also hereby confirm that there is no conflict of interest's issues in this article.
By submitting this article the author(s) agree that after publication all copyrights belong to the SPMFR Journal.
Signed by all authors
Date:
Names (capital letters):
Signatures:
The SPMFR Journal’s contents are follow a Creative Commons licence. After publication the authors can hand out the articles as long as the SPMFR Journal is credited.
